Optimal pharmacologic and non-pharmacologic management of cardiac transplant candidates: approaches to be considered prior to transplant evaluation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006.
Jessup
Mariell
M
International Society for Heart and Lung Transplantation, Addison, Texas 75001, USA.
Banner
Nicholas
N
Brozena
Susan
S
Campana
Carlo
C
Costard-Jäckle
Angelika
A
Dengler
Thomas
T
Hunt
Sharon
S
Metra
Marco
M
Rahmel
Axel
A
Renlund
Dale
D
Ross
Heather
H
Warner Stevenson
Lynne
L
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D006328:Cardiac Catheterization; D002303:Cardiac Output, Low / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy*; D002316:Cardiotonic Agents; D001026:Coronary Artery Bypass; D019468:Disease Management; D015444:Exercise; D016027:Heart Transplantation; D006801:Humans; D011300:Preoperative Care / Q000379:methods*; D012893:Sleep Wake Disorders; D049994:Sodium Potassium Chloride Symporter Inhibitors / Q000627:therapeutic use; D013727:Terminal Care; D014882:Water-Electrolyte Balance / Q000502:physiology
D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D002316:Cardiotonic Agents; D049994:Sodium Potassium Chloride Symporter Inhibitors